PA
Profund Advisors Portfolio holdings
AUM
$2.78B
This Quarter Return
-8.77%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.75B
AUM Growth
+$1.75B
(-27%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-23.43%
Top 10 Holdings %
Top 10 Hldgs %
30.33%
Holding
1,510
New
37
Increased
63
Reduced
1,107
Closed
303
Top Buys
| 1 |
Netflix
NFLX
|
$6.03M |
| 2 |
Kraft Heinz
KHC
|
$5.16M |
| 3 |
PayPal
PYPL
|
$3.35M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$2.44M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.31M |
Top Sells
| 1 |
Apple
AAPL
|
$10.8M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$6.94M |
| 3 |
Johnson & Johnson
JNJ
|
$6.92M |
| 4 |
Gilead Sciences
GILD
|
$6.63M |
| 5 |
AbbVie
ABBV
|
$6.42M |
Sector Composition
| 1 | Healthcare | 41.91% |
| 2 | Technology | 11.18% |
| 3 | Communication Services | 7.56% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Financials | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $111M | 6.32% | 1,129,491 -67,551 | -6% | -$6.63M |
|
2
Amgen
AMGN
$155B
| $80.7M | 4.6% | 583,403 -35,737 | -6% | -$4.94M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $65.8M | 3.75% | 608,337 -37,625 | -6% | -$4.07M |
|
|
4
AbbVie
ABBV
$372B
| $64.9M | 3.7% | 1,193,683 -117,914 | -9% | -$6.42M |
|
5
Biogen
BIIB
$19.4B
| $52.8M | 3.01% | 180,848 -10,728 | -6% | -$3.13M |
|
|
6
Apple
AAPL
$3.45T
| $43.8M | 2.5% | 397,126 -97,888 | -20% | -$10.8M |
|
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $32.7M | 1.86% | 52,470 -11,143 | -18% | -$6.94M |
|
8
Regeneron Pharmaceuticals
REGN
$61.5B
| $28.2M | 1.61% | 60,623 -2,126 | -3% | -$989K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $27.2M | 1.55% | 173,970 -7,217 | -4% | -$1.13M |
|
10
Amazon
AMZN
$2.44T
| $25.2M | 1.44% | 49,224 -7,629 | -13% | -$3.91M |
|
11
Microsoft
MSFT
$3.77T
| $24.6M | 1.4% | 555,094 -137,670 | -20% | -$6.09M |
|
|
12
Johnson & Johnson
JNJ
$427B
| $24.5M | 1.4% | 262,339 -74,144 | -22% | -$6.92M |
|
13
Meta Platforms (Facebook)
META
$1.86T
| $20.3M | 1.16% | 225,637 -34,109 | -13% | -$3.07M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $19.6M | 1.12% | 188,107 -10,171 | -5% | -$1.06M |
|
15
Illumina
ILMN
$15.8B
| $19.2M | 1.1% | 109,466 -5,553 | -5% | -$976K |
|
16
Pfizer
PFE
$141B
| $17.8M | 1.01% | 565,130 -172,649 | -23% | -$5.42M |
|
17
Exxon Mobil
XOM
$487B
| $17.3M | 0.99% | 233,190 -51,151 | -18% | -$3.8M |
|
18
Intel
INTC
$107B
| $13.3M | 0.76% | 440,460 -177,293 | -29% | -$5.34M |
|
19
Merck
MRK
$210B
| $13.2M | 0.75% | 266,651 -76,218 | -22% | -$3.76M |
|
20
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.8M | 0.73% | 121,874 +2,145 | +2% | +$226K |
|
21
Incyte
INCY
$16.5B
| $12.8M | 0.73% | 116,296 -5,365 | -4% | -$592K |
|
|
BXLT
22
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $12.3M | 0.7% | 389,853 +19,634 | +5% | +$619K |
|
23
Comcast
CMCSA
$125B
| $10.1M | 0.58% | 178,138 -56,554 | -24% | -$3.22M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $10.1M | 0.57% | 37,071 -9,951 | -21% | -$2.7M |
|
25
Bristol-Myers Squibb
BMY
$96B
| $9.16M | 0.52% | 154,786 -44,549 | -22% | -$2.64M |
|